Open AccessReal Life Experience of Combining Atezolizumab (Immunotherapy) and Bevacizumab (Antiangiogenic Agent) in Patients with Unresectable Hepatocellular Carcinoma in Bangladesh
Author(s) -
Mamun Al Mahtab,
Abdur Rahim,
Musarrat Mahtab,
Proshikha Saha,
Sheikh Mohammad Fazle Akbar
Publication year - 2022
Publication title -
acta scientific medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2582-0931
DOI - 10.31080/asms.2022.06.1295
Subject(s) - atezolizumab , bevacizumab , hepatocellular carcinoma , medicine , oncology , immunotherapy , cancer , chemotherapy , nivolumab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom